Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INFLUENZA VACCINE, ADJUVANTED
- An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
- Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
- FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care
- Influenza Vaccine Responses
- Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4
- Two Doses of Multimeric-001 (M-001) Followed by Two Doses of an Influenza A/H7N9 Vaccine
- A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
- H7N9 Mix and Match With MF59 in Healthy Elderly Persons
- A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1
- Efficacy and Safety of Influenza Vaccine During Sarcoidosis
- H5N1 Mix and Match With AS03
- H5N1 Mix and Match With MF59
- Swine Flu (Influenza A H1N1) Follow on Vaccine Study
- Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
- Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
- H5 Vaccine Alone or With Adjuvant in Healthy Adults
- Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults
Clinical trials list
click for details